New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
16:09 EDTNVAXNovavax' Phase I RSV vaccine data published in Vaccine
Novavax today announced that the journal Vaccine has published the company's data from its 2011 Phase I clinical trial of its respiratory syncytial virus, RSV, fusion, F,recombinant nanoparticle vaccine candidate. The paper was authored by a team of researchers and clinicians at Novavax and Dr. Pedro Piedra of Baylor College of Medicine. Findings from the trial were announced in October 2011 and presented in September by Novavax at the Respiratory Virus Symposium,RSV 2012, meeting in Santa Fe, New Mexico.
News For NVAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
09:21 EDTNVAXOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTNVAXNovavax granted FDA fast track designation to RSV F vaccine
Novavax announced that the FDA has granted Fast Track Designation to Novavax' RSV F-Protein nanoparticle vaccine candidate, or RSV F vaccine, for protection of infants via maternal immunization.
November 17, 2014
16:10 EDTNVAXNovavax initiates Phase 2 clinical trial of quadrivalent seasonal influenza VLP
Subscribe for More Information
November 14, 2014
17:14 EDTNVAXNovavax initiates phase 2 clinical trial of RSV vaccine in elderly subjects
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use